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under the receiver operating characteristics curve of Pvr, 
PPV and SVV for predicting FR was 0.75, 0.73 and 0.72, 
respectively. Changes in Pmsa, Pvr and  EH reflect changes 
in effective circulating volume and heart performance fol-
lowing fluid resuscitation, providing a physiologic dis-
crimination between responders and non-responders. Also, 
Pvr predicts FR equivalently compared to PPV and SVV, 
and might therefore aid in predicting FR in case dynamic 
preload variables cannot be used.
Keywords Hemodynamic monitoring · Fluid 
resuscitation · Circulating volume · Dynamic variables · 
Venous return · Mean systemic filling pressure · Liver 
surgery
1 Introduction
The basis of hemodynamic management in critically ill 
patients and in patients undergoing major surgery is formed 
by a rational titration of fluids, vasopressors and inotropes, 
with the ultimate goal to maintain sufficient tissue oxygen 
delivery [1]. In recent years, studies suggest that a so-called 
(early) goal-directed fluid therapy (GDFT) might reduce 
post-operative complications [2, 3]. A hallmark feature of 
most of the GDFT approaches is the assessment of fluid 
responsiveness (FR), i.e. to assess whether cardiac out-
put (CO) will increase following a fluid bolus. Dynamic 
preload variables, such as pulse pressure variation  and 
stroke volume variation (PPV and SVV, respectively), are 
currently the clinical gold standard for the prediction of FR 
[4–6]. Nevertheless, the use of these variables is limited 
by several factors [7–9] such as cardiac arrhythmias and 
(assisted) spontaneous breathing [10]. In addition, dynamic 
preload variables only provide a partial, simplified picture 
Abstract To assess the significance of an analogue of 
the mean systemic filling pressure (Pmsa) and its derived 
variables, in providing a physiology based discrimination 
between responders and non-responders to fluid resusci-
tation during liver surgery. A post-hoc analysis of data 
from 30 patients undergoing major hepatic surgery was 
performed. Patients received 15  ml  kg−1 fluid in 30  min. 
Fluid responsiveness (FR) was defined as an increase of 
20% or greater in cardiac index, measured by FloTrac- 
Vigileo®. Dynamic preload variables (pulse pressure varia-
tion and stroke volume variation: PPV, SVV) were recorded 
additionally. Pvr, the driving pressure for venous return 
(=Pmsa–central venous pressure) and heart performance 
 (EH; Pvr/Pmsa) were calculated according to standard for-
mula. Pmsa increased following fluid administration in 
responders (n = 18; from 13 ± 3 to 17 ± 4 mmHg, p < 0.01) 
and in non-responders (n = 12; from 14 ± 4 to 17 ± 4 mmHg, 
p < 0.01). Pvr, which was lower in responders before fluid 
administration (6 ± 1 vs. 7 ± 1 mmHg; p = 0.02), increased 
after fluid administration only in responders (from 6 ± 1 to 
8 ± 1 mmHg; p < 0.01).  EH only decreased in non-respond-
ers (from 0.56 ± 0.17 to 0.45 ± 0.12; p < 0.05). The area 
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of the circulation and do not provide a quantitative estima-
tion of the actual volume status. In more recent studies, the 
usefulness of the mean circulatory filling pressure (Pmsf) 
in guiding hemodynamic therapy has been investigated 
[11–14]. In short, Pmsf is the intravascular pressure that 
resides when there is no flow, i.e. after cardiac arrest has 
ensued [13, 15–17]. Pmsf is determined both by vascular 
filling and vascular tone and represents the driving pressure 
for the return of blood to the heart and thus for CO [18]. 
Subsequently, the true driving force of the circulation of 
blood is the pressure gradient for venous return (Pvr), i.e. 
the pressure difference between Pmsf and the right atrial 
pressure (or central venous pressure, CVP) [18]. Pmsf can 
be measured intermittently either during inspiratory hold 
maneuvers or during arm stop-flow measurement [12, 19, 
20]. Also, an analogue of Pmsf (Pmsa) can be monitored 
continuously at the bedside [12, 13]. Here, Pmsa is calcu-
lated using an algorithm introduced by Parkin [21]. This 
algorithm incorporates actually measured conventional 
hemodynamic variables (MAP, CVP, CO) and patient char-
acteristics (age, weight, length) in order to calculate Pmsa, 
and subsequently to calculate Pvr. Additionally, the Parkin 
algorithm allows calculating efficiency of the heart  (EH), 
which is defined as Pvr/Pmsa, and yields a dimensionless 
variable ranging from 0 to 1. The significance of Pmsa, Pvr 
and  EH in FR compared to dynamic preload variables still 
have to be investigated.
Therefore, the aim of this study was to evaluate the 
changes in Pvr, PPV and SVV in both responders and non-
responders to fluid administration. Secondly, we aimed to 
elucidate the changes in Pmsa, Pvr and  EH following fluid 
administration to allow a further physiologically based dif-
ferentiation between fluid responders and non-responders.
2  Methods
The current study is a post-hoc analysis of a randomized 
controlled trial performed in 30 patients undergoing major 
hepatic resection in whom we investigated the reliabil-
ity of non-invasive measurement of hemoglobin concen-
tration [22] and the ability of dynamic preload variables 
to predict FR [4], by administration of a 15 ml  kg−1 fluid 
bolus directly after completion of hepatic resection. In 
accordance with the Helsinki declaration, the original 
study was approved by the local medical ethics commit-
tee (Ref: 2009/174, University Medical Centre Groningen, 
The Netherlands) and has been registered at clinicaltrials.
gov (NCT01060683). Only ASA I—III patients who were 
scheduled for major hepatic resection were included after 
written informed consent had been obtained. Given that the 
current study represents a post-hoc analysis of de-identified 
data from a non-public database, no additional approval 
of the medical ethics committee or additional written 
informed consent was obtained.
In the original study, cardiac output-based data were 
obtained as part of routine clinical monitoring. Further-
more, each patient served as his/her own control.
Patients were excluded in case of intra-operatively diag-
nosed incurable disease, cardiac dysrhythmia or require-
ment of additional intravenous fluids to maintain hemody-
namic stability before the fluid bolus was administered (the 
latter was required for the aim of the original study) [22].
2.1  Anesthetic management
All patients received a standardized balanced general anes-
thesia after placement of a thoracic epidural catheter, as 
previously described [4, 22]. Patients were mechanically 
ventilated (volume-controlled mode) with tidal volumes 
of 8 ml  kg−1 lean body mass, with PEEP set at 5 cmH2O. 
The dosage of continuously adminstered norepinephrine 
was titrated to keep MAP between 60 and 80 mmHg. Dur-
ing the phase of hepatic resection, all patients received 
6 ml  kg−1  hr−1 crystalloids (NaCl 0.9%, Baxter, Deerfield, 
IL, USA) as baseline infusion. After completion of hepatic 
(parenchymal) resection—but before surgical closure of 
the abdomen—patients were allocated to receive a 15  ml 
 kg−1 fluid bolus of either crystalloids (n = 15) or colloids 
(n = 15) in a fixed time frame of 30 min.
FR was defined as an increase in CO, indexed to BSA 
(Cardiac Index, CI) by at least 20% after fluid administra-
tion. A higher-than-normal definition of FR was applied 
because of both the relatively large amount of fluid admin-
istered during the resuscitation phase and the increased 
discriminative ability of dynamic variables to predict FR in 
case of higher FR thresholds [23].
2.2  Hemodynamic monitoring
All measurements took place during the 30 min period of 
fluid administration.
MAP was monitored invasively using a 20  G radial 
artery catheter and the pressure transducer was connected 
to the vital signs monitor (Philips MP70; Philips, Eind-
hoven, Netherlands). The FloTrac-Vigileo® device (soft-
ware V03.02, used in all patients) was connected to the 
arterial pressure transducer for continuous calculation of 
CO using an automated auto-calibrated analysis of the arte-
rial pressure waveform. Additionally, this device calculates 
stroke volume variation (SVV) over a 20  s period using 
the formula: SVV = (SV
max
− SV
min
)∕SV
mean
. PPV was 
calculated subsequently over the equivalent time frame as 
PPV =
(
PPV
max
− PPV
min
)
∕ PPV
mean
, using dedicated 
software developed by the authors. Obvious artefacts were 
eliminated by visual inspection of the waveforms.
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CVP was continuously recorded after cannulation of the 
right internal jugular vein using a 7  F triple lumen cath-
eter. Both the arterial and central venous pressure transduc-
ers were zeroed and thereafter adjusted to the height of the 
right atrium.
The calculation of Pmsa is based on the Par-
kin algorithm [21], which follows the equation: 
Pmsa = a(CVP) + b(MAP) + c(CO). Here, a and b are 
constant values (a + b = 1), without dimension and, based 
on an assumed veno-arterial compliance ratio of 24:1, 
a = 0.96 and b = 0.04. The value of c depends on age, 
weight and height, and resembles arteriovenous resistance. 
The interested reader is referred to the original publication 
for more detailed information [21]. Pmsa has been vali-
dated in experimental and clinical studies [12, 14].
Handling of data recording of the hemodynamic data 
was described previously [4]. All data were synchronized 
and were exported to Microsoft Excel 2010 (Microsoft, 
Redwood, MS, USA) for statistical analysis.
2.3  Statistical analysis
Continuous variables were tested for normal distribution 
using the Kolmogorov–Smirnoff test. Normally distributed 
variables were tested using the paired or unpaired Student’s 
t-test. Non-normally distributed data were tested using the 
(paired) Mann–Whitney test or (unpaired) Kruskal–Wallis 
test.
Correlation between relevant variables was depicted as 
a scatter plot and coefficients of determination (R² values) 
were calculated.
The ability of dynamic preload variables and Pvr to 
predict FR was assessed using receiver operating charac-
teristic (ROC) analysis. The areas under the ROC curve 
(AUROC’s) were compared using the DeLong methodol-
ogy [24].
Statistical significance was set at p < 0.05. Data are pre-
sented as mean ± standard deviation.
3  Results
A total of 30 patients (14 male, 16 female) received a 
fluid bolus and were included for analysis. Mean age of all 
patients was 57 ± 13 years, mean height and weight were 
176 ± 7 cm and 80 ± 13 kg, respectively.
18/30 patients demonstrated an increase in CI > 20% 
and were regarded as fluid responders; consequently, 12/30 
patients were regarded as non-responders.
Hemodynamic variables at baseline and after fluid 
administration are summarized in Table  1 both for fluid 
responders and non-responders.
3.1  Fluid administration and changes in Pmsa, Pvr,  EH, 
and dynamic preload variables
Pmsa was comparable between responders and non-
responders at baseline (13 ± 3 vs. 14 ± 4  mmHg; p = 0.28, 
Table  1). Pmsa increased both in responders and in non-
responders to 17 ± 4 mmHg (p < 0.01 for both groups) after 
fluid administration.
Table 1  Hemodynamic 
variables at baseline and after 
fluid bolus administration
Data are presented as mean ± SD
MAP Mean Arterial Pressure, CVP Central Venous Pressure, CI Cardiac Index, PPV pulse pressure varia-
tion, SVV stroke volume variation, Pmsa mean systemic filling pressure analogue, Pvr driving pressure for 
venous return, EH cardiac performance
*Indicates p < 0.05 versus non-responder group
# Indicates p < 0.05 versus value before fluid administration
Non-responders (n = 12) Responders (n = 18)
Baseline After Baseline After
Heart rate (bpm) 80 ± 14 79 ± 10 90 ± 19 89 ± 16
MAP (mmHg) 75 ± 11 71 ± 9 73 ± 11 76 ± 9
CVP (mmHg) 7 ± 4 9 ± 4# 6 ± 3 8 ± 5
CI (L  min−1 m−2) 3.1 ± 0.8 3.2 ± 1.0 2.9 ± 0.8 4.2 ± 1.2*,#
PPV (%) 16 ± 9 9 ± 5# 23 ± 11* 9 ± 7#
SVV (%) 12 ± 6 10 ± 5# 17 ± 8* 7 ± 4*,#
Pmsa (mmHg) 14 ± 4 17 ± 4# 13 ± 3 17 ± 4#
Pvr (mmHg) 7 ± 1 7 ± 2 6 ± 1* 8 ± 1*,#
RVR (mmHg  min−1 m−2 L−1) 2.3 (0.4) 2.2 (0.4) 2.5 (0.6) 2.1 (0.4)#
EH 0.56 ± 0.17 0.45 ± 0.12# 0.52 ± 0.11 0.49 ± 0.12
Norepinephrine dosage (µg  kg−1 min−1) 0.16 ± 0.21 0.13 ± 0.15 0.13 ± 0.15 0.12 ± 0.12
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Pvr (= Pmsa–CVP) was lower in responders than in non-
responders at baseline (6 ± 1 vs. 7 ± 1  mmHg, p = 0.02). 
Moreover, Pvr only increased in responders (6 ± 1 to 
8 ± 1 mmHg, p < 0.01) after fluid administration. In Fig. 1, 
the distribution of baseline values of PPV, SVV and Pvr is 
shown seperately for responders and non-responders.
Heart Performance  (EH) was comparable between 
responders (0.52 ± 0.11) and non-responders (0.56 ± 0.17) 
at baseline (p = 0.47). Importantly,  EH decreased follow-
ing fluid administration in non-responders to 0.45 ± 0.12 
(p < 0.01) but remained stable in the responders group 
(0.49 ± 0.12, p = 0.16). The resistance to venous return 
(RVR) did not differ between both groups at baseline. In 
responders, RVR decreased after fluid administration [from 
2.5 ± 0.6 to 2.1 ± 0.4 mmHg  min−1    m−2  L−1   (p < 0.01)], 
while it remained unchanged in non-responders.
Norepinephrine dosages at baseline were not signifi-
cantly correlated with Pmsa, Pvr, RVR or  EH (all  R2 val-
ues <0.1), which was also true after fluid administration 
(also, all  R2 values <0.1).
3.2  Prediction of fluid responsiveness (FR)
The AUROC of Pvr in predicting FR was 0.75 (95% Con-
fidence Interval (CI): 0.57–0.93; p < 0.05, Fig.  2). The 
AUROC of PPV was 0.73 (CI: 0.54–0.92; p < 0.05), while 
that of SVV was 0.72 (CI: 0.53–0.91; p < 0.05), Fig. 2.
There were no significant differences between the 
observed AUROC’s. The optimal cut-off value for Pvr was 
7  mmHg with an associated sensitivity and specificity of 
72% and 75%, respectively. The optimal cut-off values for 
PPV and SVV were 14% and 16% respectively, with asso-
ciated sensitivity and specificity values of 83/58% and 
56/91%, respectively.
Of note, the AUROC of Pmsa and  EH to predict FR was 
not significant (0.48 and 0.41, respectively).
There was a moderate correlation between Pvr and CI 
at baseline  (R2 = 0.37; p < 0.01, Fig. 3) with no difference 
between responders and non-responders. Furthermore, 
the change in CI following fluid administration (∆CI) 
was strongly correlated with the corresponding change in 
Pvr (∆Pvr)  (R2 = 0.93; p < 0.01; Fig.  4). Of the change in 
dynamic preload variables, only ∆SVV inversely correlated 
with ∆CI  (R2 0.18, p < 0.01), whereas ∆PPV did not  (R2 
0.05, p = 0.25) (data not shown; no differences between 
responders and non-responders).
Fig. 1  Shown are baseline 
individual values of SVV 
(blue), PPV (red) and Pvr 
(green) both for responders (R) 
and non-responders (NR) to 
fluid administration. The dashed 
grey lines represent the optimal 
cut-off value, as determined by 
ROC analysis
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Fig. 2  Receiver operator characteristics (ROC) Curve for assessing 
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and SVV (black dashed line). Also given are the optimal cut-off val-
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4  Discussion
In this study, we evaluated the effects of fluid administra-
tion on the effective circulating blood volume using a car-
diovascular model.
Firstly, the model-derived variables closely followed 
theoretically predicted volume-induced changes and allow 
a more detailed differentiation between fluid responders 
and non-responders. Pmsa increased in both groups follow-
ing fluid administration. Yet, in responders, CVP did not 
change and as such, Pvr (Pmsa–CVP) increased which led 
to an increase in CI. In other words, the heart was able to 
generate more output from the increase in venous return. In 
non-responders, CVP increased to a similar extent as Pmsa 
and the increase in CVP helps reducing venous return.
Importantly,  EH, decreased as the heart was unable to 
handle the increase in venous return, while in responders 
 EH remaine stable, i.e. the efficiency of the heart in han-
dling an increase in venous return was maintained.
Secondly, the observation that PPV, SVV and Pvr pre-
dict FR equivalently, might suggest that Pvr can be used 
alternatively for the prediction of FR  in case the former 
variables cannot be used.
4.1  Physiologic differentiation between fluid responders 
and non-responders
CO is determined by the effective circulating blood vol-
ume (ECBV), the resistance to venous return and the pres-
sure within the right atrium [25]. Pmsa, as a surrogate of 
ECBV, is determined both by vascular filling and tone and 
provides a pressure variable for the determination of flow, 
i.e. venous return. Subsequently, Pvr functions as the driv-
ing pressure for generating venous return and hence, CO. 
The current data support this theory because, according 
to our definition of FR (i.e. an increase in CI > 20%), Pvr 
increased in responders but remained unchanged in non-
responders—a finding that was previously also observed in 
post-cardiac surgery patients receiving even a more “sub-
tle” fluid challenge (250 ml) in comparison with our study 
[13]. In physiologic terms, these observations suggest that 
in fluid responders, the heart is able to handle the increase 
in Pmsa by generating more output, numerically reflected 
by an increase in Pvr. In non-responders, the increase in 
Pmsa cannot be handled by the heart. CVP increases pas-
sively, as a consequence of both increased venous return 
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Fig. 4  Scatter plot showing 
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and impaired cardiac function, a mechanism described in 
more detail previously [26].
EH (Pvr/Pmsa) reflects the Pvr—Pmsa relationship: it 
decreased significantly in non-responders, but remained 
unchanged in responders. As explained above, this obser-
vation might indicate that in these patients the heart was 
unable to handle the increase in Pmsa and thus, these 
patients did not benefit from fluid, i.e. these patients were 
likely to be (already) on the “flat” part of their Frank-Star-
ling curve. We therefore speculate that this variable might 
be used clinically to monitor the effects of fluid adminis-
tration on cardiac performance itself. Potentially,  EH might 
also demonstrate the (combined) effects of fluid adminis-
tration and other factors such as inotropic medication on 
cardiac performance. Future studies should confirm the 
potential use of  EH. Interestingly—as patients were rand-
omized to receive either crystalloids or colloids—we found 
no differences in Pmsa or derived FR variables between 
these groups. Given the controversial differences between 
the intravascular effects of these fluids, this finding might 
be contrary to expectations, although this post-hoc analy-
sis was not set up to study differences between fluid types, 
and studying these effects probably requires a larger sample 
size.
We observed a decrease in RVR (Pvr/CI) in responders, 
which is likely given that RVR will decrease if the increase 
in CI exceeds the increase in Pvr. This observation how-
ever contrasts previous reports in which RVR remained sta-
ble after either changes in norepinephrine dosage in septic 
shock patients [27] or after fluid administration in a mixed 
post-surgical ICU population [13]. Given our limited sam-
ple size and the complexity of our combined intervention 
(fluid administration, norepinephrine dosage changes), we 
cannot draw any (further) conclusions other than that the 
decrease in RVR in responders follows theoretically pre-
dicted physiologic changes.
4.2  The assessment of fluid responsiveness (FR)
Currently, in sedated and mechanically ventilated patients, 
dynamic (preload) variables like PPV and SVV are estab-
lished predictors of FR—both perioperatively and in the 
ICU—and these variables have been found superior to 
static variables like CVP and pulmonary capillary  wedge 
pressure [3–5, 28–30] Like CVP, isolated pressure values 
such as Pmsa are inadequate predictors of FR, as demon-
strated by an AUROC of 0.48 in our study. These static var-
iables should therefore not be used solely [31] as a surro-
gate for indicating flow. Theoretically, this is also expected 
to apply to Pvr. Yet, We observed that FR prediction by Pvr 
is comparable to that of dynamic preload variables. Also, 
Pvr and CI were moderately correlated. These observations 
imply that Pvr might be used alternatively for predicting 
FR [32].
Interestingly, the ability to predict FR by dynamic 
preload variables was lower than generally reported in lit-
erature [5, 30], even though none of the recognized fac-
tors [7–9] limiting the accuracy of dynamic variables 
(e.g. spontaneous breathing activity, cardiac arrhytmia) 
was present in any of our patients. As measurements were 
obtained during ongoing hepatic surgery, we cannot rule 
out that surgical manipulation with subsequent alteration(s) 
of venous return, might be responsible for the decreased 
accuracy of dynamic variables. Also, while we found no 
differences between PPV, SVV and Pvr in predicting FR, 
the number of studied patients (n = 30) was relatively low 
(as reflected by relatively wide AUROC confidence inter-
vals). It is important to reckon that results were based on 
one definition of FR (i.e. an increase of CI > 20%), while 
we have recently shown [23] that the ability of dynamic 
preload variables to predict FR is substantially dependent 
on the actual definition of FR: the differences in AUROC 
of PPV and SVV compared to our previous report [4] in 
the same population, serve as an example. A larger sample 
size would have allowed a further analysis based on multi-
ple definitions of FR and possibly the recognition of more 
subtle differences in the ability of Pvr or dynamic preload 
variables in predicting FR.
There are no recommendations for an “optimal” Pvr 
value for guiding fluid management: as an example, a Pvr 
of 5 mmHg can result from multiple combinations of Pmsa 
and CVP, such as 10/5  mmHg and 20/15  mmHg, respec-
tively. In these instances, it is questionable whether CI 
will increase to a similar extent. Therefore, future studies 
in large, perioperative patient populations or in critically 
ill patients should verify the assumed role of Pvr in pre-
dicting FR. Of note, a recent study in post-cardiac surgery 
patients suggested using the ratio between changes in Pvr 
and changes in Pmsa—called “volume efficiency”—as an 
additional predictor of FR [33].
Also, the usefulness of variables such as Pvr and  EH, 
has not yet been the subject of investigation in any (early) 
GDFT trial. Therefore, it remains to be elucidated—as 
was also recently suggested [34]—whether these vari-
ables allow us to improve hemodynamics in the individual 
patient, together with a subsequently beneficial effect on 
patient outcome.
4.3  Study limitations
Pmsf is a theoretical variable that cannot be measured clini-
cally to assess its validity, as real-life measurement would 
require circulatory arrest [15]. The calculation of its ana-
logue (Pmsa) using the Parkin algorithm [21], incorpo-
rates values of MAP, CO and CVP. An increase in CO is 
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therefore mathematically coupled to an increase in Pmsa 
and hence, the definition of FR is mathematically cou-
pled to the investigated variables Pmsa and Pvr. Ideally, 
Pmsf were assessed independently from CO. Pmsf can be 
assessed by two other methods: One of these methods uses 
inspiratory-hold maneuvers (requiring a sedated and venti-
lated patient) in which data pairs of CO and CVP are back-
extrapolated to a zero CO state [19]. The other method [12] 
assesses Pmsf using transient stop-flow arm measurements. 
These two non-CO dependent methods for assessing Pmsf 
were regarded non-feasible in our study during ongoing 
surgery. Nevertheless, previously it was shown that while 
absolute Pmsa values may slightly differ from Pmsf values 
obtained using the other two methods, changes in the three 
Pmsf estimates were linear and “calibration” of Pmsa using 
a calibration factor resulted in zero bias [12]. As such, our 
results confirm that Pmsa can be used to track fluid-induced 
volume changes, yet its absolute value might be incorrect to 
some extent [12]. Therefore, while we used a mathematical 
approach to estimate Pmsf—which is inherently coupled to 
CO—it is likely that assessing Pmsf using other methods 
would have produced similar results. Importantly, this issue 
requires further research.
It has been shown previously in septic shock patients 
that norepinephrine titration influences venous return by 
exerting effects on Pmsf and resistance to venous return 
[27]. In our study, the flow rate of continuous norepineph-
rine infusion was altered to maintain MAP between 60 and 
80 mmHg. Hence, Pmsa and other derived variables might 
have been affected by this mechanism, although we could 
not find any correlation between dosage(s) of norepineph-
rine and Pmsa or related variables. Yet, this issue deserves 
further elucidation in future dedicated research.
Finally, the applied algorithm incorporates hemody-
namic values and combines these with demographic param-
eters in order to calculate Pmsa and subsequent calculation 
of Pvr. As the algorithm for calculation of Pmsa is based 
on multiple (independent) measurements (MAP, CVP and 
CO), the measurement error of Pmsa is an accumulation 
of the individual measurement errors of each variable, e.g. 
due to variation in the location of tip of the central venous 
catheter. For the latter, we verified post-hoc the correct 
positioning of the central venous catheter in all patients.
5  Conclusions
In conclusion, bedside calculation of Pmsa, Pvr and  EH 
allow a physiology-based differentiation between respond-
ers and non-responders to fluid administration. Also, the 
ability of Pvr to predict FR was similar to that of PVV and 
SVV and therefore, Pvr might be used as an alternative 
method for predicting FR, especially in situations in which 
PPV or SVV are deemed unreliable.
Funding This study was funded by departmental funding only.
Compliance with ethical standards 
Conflict of interest The authors declare that they have no conflict 
of interest.
Ethical approval All procedures performed in studies involving 
human participants were in accordance with the ethical standards of 
the institutional and/or national research committee and with the 1964 
Helsinki declaration and its later amendments or comparable ethical 
standards.
Informed consent Informed consent was obtained from all individ-
ual participants included in the original study.
Open Access This article is distributed under the terms of the 
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted 
use, distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
 1. Shoemaker WC, Wo CC, Thangathurai D, Velmahos G, Belz-
berg H, Asensio JA, Demetriades D. Hemodynamic patterns of 
survivors and nonsurvivors during high risk elective surgical 
operations. World J Surg. 1999;23:1264–70. discussion 1270-1.
 2. Gu WJ, Wang F, Bakker J, Tang L, Liu JC. The effect of goal-
directed therapy on mortality in patients with sepsis - earlier is 
better: a meta-analysis of randomized controlled trials. Crit Care. 
2014;18:570-014-0570-5.
 3. Giglio MT, Marucci M, Testini M, Brienza N. Goal-directed 
haemodynamic therapy and gastrointestinal complications in 
major surgery: a meta-analysis of randomized controlled trials. 
Br J Anaesth. 2009;103:637–46.
 4. Vos JJ, Kalmar AF, Struys MM, Wietasch JK, Hendriks HG, 
Scheeren TW. Comparison of arterial pressure and plethysmo-
graphic waveform based dynamic preload variables in assessing 
fluid responsiveness and dynamic arterial tone in patients under-
going major hepatic resection. Br J Anaesth. 2013;110:940–6.
 5. Yang X, Du B. Does pulse pressure variation predict fluid 
responsiveness in critically ill patients? a systematic review and 
meta-analysis. Crit Care. 2014;18:650.
 6. Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in 
arterial waveform derived variables and fluid responsiveness in 
mechanically ventilated patients: a systematic review of the lit-
erature. Crit Care Med. 2009;37:2642–7.
 7. Sondergaard S. Pavane for a pulse pressure variation defunct. 
Crit Care. 2013;17:327.
 8. Maguire S, Rinehart J, Vakharia S, Cannesson M. Techni-
cal communication: respiratory variation in pulse pressure and 
plethysmographic waveforms: intraoperative applicability in a 
North American academic center. Anesth Analg. 2011;112:94–6.
 9. Piccioni F, Bernasconi F, Tramontano GT, Langer M. A sys-
tematic review of pulse pressure variation and stroke volume 
 J Clin Monit Comput
1 3
variation to predict fluid responsiveness during cardiac and 
thoracic surgery. J Clin Monit Comput. 2016. doi: 10.1007/
s10877-016-9898-5
 10. Hong DM, Lee JM, Seo JH, Min JJ, Jeon Y, Bahk JH. Pulse 
pressure variation to predict fluid responsiveness in spontane-
ously breathing patients: tidal vs. forced inspiratory breathing. 
Anaesthesia. 2014;69:717–22.
 11. Maas JJ, Pinsky MR, Aarts LP, Jansen JR. Bedside assessment 
of total systemic vascular compliance, stressed volume, and 
cardiac function curves in intensive care unit patients. Anesth 
Analg. 2012;115:880–7.
 12. Maas JJ, Pinsky MR, Geerts BF, de Wilde RB, Jansen JR. Esti-
mation of mean systemic filling pressure in postoperative car-
diac surgery patients with three methods. Intensive Care Med. 
2012;38:1452–60.
 13. Cecconi M, Aya HD, Geisen M, Ebm C, Fletcher N, Grounds 
RM, Rhodes A. Changes in the mean systemic filling pressure 
during a fluid challenge in postsurgical intensive care patients. 
Intensive Care Med. 2013;39:1299–305.
 14. Lee JM, Ogundele O, Pike F, Pinsky MR. Effect of acute endo-
toxemia on analog estimates of mean systemic pressure. J Crit 
Care. 2013;28:880.e9-880.15.
 15. Repesse X, Charron C, Fink J, Beauchet A, Deleu F, Slama M, 
Belliard G, Vieillard-Baron A. Value and determinants of the 
mean systemic filling pressure in critically ill patients. Am J 
Physiol Heart Circ Physiol. 2015;309:H1003–7.
 16. Bayliss WM, Starling EH. Observations on venous pressures 
and their relationship to capillary pressures. J Physiol. 1894; 
16:159–318.7.
 17. Pellegrino VA, Mudaliar Y, Gopalakrishnan M, Horton MD, 
Killick CJ, Parkin WG, Playford HR, Raper RF. Computer based 
haemodynamic guidance system is effective and safe in manage-
ment of postoperative cardiac surgery patients. Anaesth Intensive 
Care. 2011;39:191–201.
 18. Henderson WR, Griesdale DE, Walley KR, Sheel AW. Clini-
cal review: Guyton-the role of mean circulatory filling pressure 
and right atrial pressure in controlling cardiac output. Crit Care. 
2010;14:243.
 19. Maas JJ, Geerts BF, van den Berg PC, Pinsky MR, Jansen JR. 
Assessment of venous return curve and mean systemic filling 
pressure in postoperative cardiac surgery patients. Crit Care 
Med. 2009;37:912–8.
 20. Aya HD, Rhodes A, Fletcher N, Grounds RM, Cecconi M. Tran-
sient stop-flow arm arterial-venous equilibrium pressure meas-
urement: determination of precision of the technique. J Clin 
Monit Comput. 2016;30:55–61.
 21. Parkin G, Wright C, Bellomo R, Boyce N. Use of a mean sys-
temic filling pressure analogue during the closed-loop control of 
fluid replacement in continuous hemodiafiltration. J Crit Care. 
1994;9:124–33.
 22. Vos JJ, Kalmar AF, Struys MM, Porte RJ, Wietasch JK, 
Scheeren TW, Hendriks HG. Accuracy of non-invasive measure-
ment of haemoglobin concentration by pulse co-oximetry during 
steady state and dynamic conditions in patients undergoing liver 
surgery. Br J Anaesth. 2012;109:522–8.
 23. Vos JJ, Poterman M, Salm PP, Van Amsterdam K, Struys MM, 
Scheeren TW, Kalmar AF. Noninvasive pulse pressure varia-
tion and stroke volume variation to predict fluid responsiveness 
at multiple thresholds: a prospective observational study. Can J 
Anaesth. 2015;62:1153–60.
 24. DeLong ER, DeLong DM, Clarke-Pearson DL. Compar-
ing the areas under two or more correlated receiver operating 
characteristic curves: a nonparametric approach. Biometrics. 
1988;44:837–45.
 25. Guyton AC. Regulation of cardiac output. Anesthesiology. 
1968;29:314–26.
 26. Berlin DA, Bakker J. Understanding venous return. Intensive 
Care Med. 2014;40:1564–6.
 27. Persichini R, Silva S, Teboul J, Jozwiak M, Chemla D, Richard 
C, Monnet X. Effects of norepinephrine on mean systemic pres-
sure and venous return in human septic shock. Crit Care Med. 
2012;40:3146–53.
 28. Scheeren TW, Wiesenack C, Gerlach H, Marx G. Goal-directed 
intraoperative fluid therapy guided by stroke volume and its vari-
ation in high-risk surgical patients: a prospective randomized 
multicentre study. J Clin Monit Comput. 2013;27:225–33.
 29. Benes J, Giglio M, Brienza N, Michard F. The effects of goal-
directed fluid therapy based on dynamic parameters on post-sur-
gical outcome: a meta-analysis of randomized controlled trials. 
Crit Care. 2014;18:584-014-0584-z.
 30. Monnet X, Marik PE, Teboul JL. Prediction of fluid responsive-
ness: an update. Ann Intensive Care. 2016;6:111.
 31. Osman D, Ridel C, Ray P, Monnet X, Anguel N, Richard C, 
Teboul JL. Cardiac filling pressures are not appropriate to pre-
dict hemodynamic response to volume challenge. Crit Care Med. 
2007;35:64–8.
 32. Benes J, Zatloukal J, Kletecka J, Simanova A, Haidingerova L, 
Pradl R. Respiratory induced dynamic variations of stroke vol-
ume and its surrogates as predictors of fluid responsiveness: 
applicability in the early stages of specific critical states. J Clin 
Monit Comput. 2014;28:225–31.
 33. Gupta K, Sondergaard S, Parkin G, Leaning M, Aneman A. 
Applying mean systemic filling pressure to assess the response 
to fluid boluses in cardiac post-surgical patients. Intensive Care 
Med. 2015;41:265–72.
 34. Monnet X, Pinsky MR. Predicting the determinants of volume 
responsiveness. Intensive Care Med. 2015;41:345–6.
